{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:42:53Z","timestamp":1790728973622,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Air Force Medical University","doi-asserted-by":"publisher","award":["2022ZZXM044"],"award-info":[{"award-number":["2022ZZXM044"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Air Force Medical University","doi-asserted-by":"publisher","award":["2021JSTS10"],"award-info":[{"award-number":["2021JSTS10"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2604200"],"award-info":[{"award-number":["2022YFC2604200"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009103","name":"Education Department of Shaanxi Provincial government","doi-asserted-by":"publisher","award":["23JP194"],"award-info":[{"award-number":["23JP194"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072268"],"award-info":[{"award-number":["82072268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.imj.2026.100249","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:28:00Z","timestamp":1774312080000},"page":"100249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current status on encephalitic alphavirus vaccines development: Advances, challenges, and global health perspectives"],"prefix":"10.1016","volume":"5","author":[{"given":"Xiaojing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengnan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-8547","authenticated-orcid":false,"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3\/4","key":"10.1016\/j.imj.2026.100249_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7774\/cevr.2014.3.1.58","article-title":"Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses","volume":"3","author":"Go","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"issue":"8","key":"10.1016\/j.imj.2026.100249_bib0003","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/microorganisms8081167","article-title":"Epidemic alphaviruses: ecology, emergence and outbreaks","volume":"8","author":"Azar","year":"2020","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.imj.2026.100249_bib0004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/microorganisms7050133","article-title":"Arthritogenic alphaviruses: a worldwide emerging threat?","volume":"7","author":"Levi","year":"2019","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008876","article-title":"A molecular understanding of alphavirus entry","volume":"16","author":"Holmes","year":"2020","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.imj.2026.100249_bib0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/antib7040044","article-title":"Selection of single-domain antibodies towards western equine encephalitis virus","volume":"7","author":"Liu","year":"2018","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.imj.2026.100249_bib0008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2019.01.015","article-title":"New World alphavirus protein interactomes from a therapeutic perspective","volume":"163","author":"Carey","year":"2019","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2025.100167","article-title":"Eastern equine encephalitis virus: pathogenesis, immune response, and clinical manifestations","volume":"4","author":"Parashar","year":"2025","journal-title":"Infect Med"},{"key":"10.1016\/j.imj.2026.100249_bib0010","doi-asserted-by":"crossref","unstructured":"Meltzer E. Arboviruses and viral hemorrhagic fevers (VHF). Infect Dis Clin North Am. 2012; 26(2): 479\u2013496. https:\/\/doi.org\/10.1016\/j.idc.2012.02.003.","DOI":"10.1016\/j.idc.2012.02.003"},{"issue":"2","key":"10.1016\/j.imj.2026.100249_bib0011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/v15020413","article-title":"Advances in the development of small molecule antivirals against equine encephalitic viruses","volume":"15","author":"Ogorek","year":"2023","journal-title":"Viruses"},{"issue":"7324","key":"10.1016\/j.imj.2026.100249_bib0012","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature09546","article-title":"Structural changes of envelope proteins during alphavirus fusion","volume":"468","author":"Li","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.imj.2026.100249_bib0013","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41579-022-00825-7","article-title":"A molecular understanding of alphavirus entry and antibody protection","volume":"21","author":"Kim","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0014","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/v9100279","article-title":"Venezuelan equine encephalitis virus capsid-the clever caper","volume":"9","author":"Lundberg","year":"2017","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.imj.2026.100249_bib0015","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1099\/jgv.0.000249","article-title":"Alphavirus RNA synthesis and non-structural protein functions","volume":"96","author":"Rupp","year":"2015","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00303-8","article-title":"The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH","volume":"105","author":"Lescar","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imj.2026.100249_bib0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coviro.2013.04.003","article-title":"Alphavirus structure: activation for entry at the target cell surface","volume":"3","author":"Vaney","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"18","key":"10.1016\/j.imj.2026.100249_bib0018","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1128\/JVI.01507-13","article-title":"The role of E3 in pH protection during alphavirus assembly and exit","volume":"87","author":"Uchime","year":"2013","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.imj.2026.100249_bib0019","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/fmb.09.59","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Jose","year":"2009","journal-title":"Future Microbiol"},{"issue":"16","key":"10.1016\/j.imj.2026.100249_bib0020","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1128\/JVI.75.16.7778-7784.2001","article-title":"Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans","volume":"75","author":"Sanz","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010892","article-title":"Requirement of a functional ion channel for Sindbis virus glycoprotein transport, CPV-II formation, and efficient virus budding","volume":"18","author":"Elmasri","year":"2022","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0022","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1128\/JVI.00130-11","article-title":"Activation of the alphavirus spike protein is suppressed by bound E3","volume":"85","author":"Sj\u00f6berg","year":"2011","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.imj.2026.100249_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006061","article-title":"Intercellular extensions are induced by the alphavirus structural proteins and mediate virus transmission","volume":"12","author":"Martinez","year":"2016","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.imj.2026.100249_bib0024","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41564-023-01449-0","article-title":"Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo","volume":"8","author":"Yin","year":"2023","journal-title":"Nat Microbiol"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0025","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/v16111762","article-title":"Self-replicating alphaviruses: from pathogens to therapeutic agents","volume":"16","author":"Lundstrom","year":"2024","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.imj.2026.100249_bib0026","doi-asserted-by":"crossref","first-page":"952","DOI":"10.4269\/ajtmh.1998.59.952","article-title":"Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex","volume":"59","author":"Kinney","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.imj.2026.100249_bib0027","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/jvi.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.imj.2026.100249_bib0028","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/infdis\/136.3.354","article-title":"Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine","volume":"136","author":"Burke","year":"1977","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.imj.2026.100249_bib0029","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/vaccines8020273","article-title":"Vaccine advances against venezuelan, eastern, and western equine encephalitis viruses","volume":"8","author":"Stromberg","year":"2020","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.imj.2026.100249_bib0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4269\/ajtmh.1967.16.762","article-title":"Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man","volume":"16","author":"Alevizatos","year":"1967","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.imj.2026.100249_bib0031","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4269\/ajtmh.1963.12.597","article-title":"Use of an attenuated strain of venezuelan equine encephalomyelitis virus for immunization in man","volume":"12","author":"McKinney","year":"1963","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.imj.2026.100249_bib0032","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2020.11.010","article-title":"Designing multivalent immunogens for alphavirus vaccine optimization","volume":"561","author":"Read","year":"2021","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0033","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"issue":"3\/4","key":"10.1016\/j.imj.2026.100249_bib0034","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0264-410X(01)00337-1","article-title":"Onset and duration of protective immunity to IA\/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice","volume":"20","author":"Hart","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.imj.2026.100249_bib0035","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0036","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imj.2026.100249_bib0037","doi-asserted-by":"crossref","first-page":"2","DOI":"10.15212\/ZOONOSES-2021-0016","article-title":"Venezuelan equine encephalitis virus V3526 vaccine RNA-dependent RNA polymerase mutants increase vaccine safety through restricted tissue tropism in a murine model","volume":"2","author":"Haines","year":"2022","journal-title":"Zoonoses"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0038","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/infdis\/140.5.708","article-title":"Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84)","volume":"140","author":"Edelman","year":"1979","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.imj.2026.100249_bib0039","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.1890380414","article-title":"Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine","volume":"38","author":"Engler","year":"1992","journal-title":"J Med Virol"},{"key":"10.1016\/j.imj.2026.100249_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.555464","article-title":"The western equine encephalitis lyophilized, inactivated vaccine: an update on safety and immunogenicity","volume":"11","author":"Keshtkar-Jahromi","year":"2020","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.imj.2026.100249_bib0041","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.vaccine.2021.03.030","article-title":"Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine","volume":"39","author":"Pierson","year":"2021","journal-title":"Vaccine"},{"issue":"818","key":"10.1016\/j.imj.2026.100249_bib0042","doi-asserted-by":"crossref","first-page":"eadv7079","DOI":"10.1126\/scitranslmed.adv7079","article-title":"An inactivated trivalent virion-based vaccine protects against aerosol challenge with encephalitic alphaviruses in mice and macaques","volume":"17","author":"LKM","year":"2025","journal-title":"Sci Transl Med"},{"issue":"17\/18","key":"10.1016\/j.imj.2026.100249_bib0043","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2005.01.032","article-title":"Efficacy of DNA vaccination against western equine encephalitis virus infection","volume":"23","author":"Nagata","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0044","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/CVI.00377-09","article-title":"Identification of western equine encephalitis virus structural proteins that confer protection after DNA vaccination","volume":"17","author":"Gauci","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.imj.2026.100249_bib0045","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JVI.02554-09","article-title":"Venezuelan equine Encephalitis virus capsid protein forms a tetrameric complex with CRM1 and importin alpha\/beta that obstructs nuclear pore complex function","volume":"84","author":"Atasheva","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.imj.2026.100249_bib0046","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8521060","volume":"2018","author":"Dupuy","year":"2018","journal-title":"J Immunol Res"},{"issue":"25\/26","key":"10.1016\/j.imj.2026.100249_bib0047","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0048","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"31","key":"10.1016\/j.imj.2026.100249_bib0049","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2016.04.077","article-title":"A phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation","volume":"34","author":"Hannaman","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41541-022-00469-x","article-title":"A DNA vaccine targeting VEE virus delivered by needle-free jet-injection protects macaques against aerosol challenge","volume":"7","author":"Suschak","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"25","key":"10.1016\/j.imj.2026.100249_bib0051","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1016\/j.vaccine.2019.04.072","article-title":"Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome","volume":"37","author":"Tretyakova","year":"2019","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.imj.2026.100249_bib0052","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/pharmaceutics16091217","article-title":"Replication of the venezuelan equine encephalitis vaccine from a synthetic PCR fragment","volume":"16","author":"Mathew","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.imj.2026.100249_bib0053","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2025.02.008","article-title":"Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum","volume":"380","author":"Hong","year":"2025","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.imj.2026.100249_bib0054","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/v17081136","article-title":"V4020 venezuelan equine encephalitis vaccine: mitigating neuroinvasion and reversion through rational design","volume":"17","author":"Centers","year":"2025","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.imj.2026.100249_bib0055","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1080\/21645515.2017.1329788","article-title":"An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice","volume":"13","author":"Bounds","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0056","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307798120","article-title":"Recent advances in nanoparticulate RNA delivery systems","volume":"121","author":"Witten","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0057","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12951-023-01938-8","article-title":"Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants","volume":"21","author":"Sharifi","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0058","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/vaccines9101187","article-title":"Self-replicating RNA viruses for vaccine development against infectious diseases and cancer","volume":"9","author":"Lundstrom","year":"2021","journal-title":"Vaccines"},{"issue":"33","key":"10.1016\/j.imj.2026.100249_bib0059","doi-asserted-by":"crossref","first-page":"20006","DOI":"10.1039\/D0RA09668G","article-title":"A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2","volume":"11","author":"Damodharan","year":"2021","journal-title":"RSC Adv"},{"issue":"4","key":"10.1016\/j.imj.2026.100249_bib0060","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ymthe.2018.12.013","article-title":"Self-amplifying RNA vaccines for venezuelan equine encephalitis virus induce robust protective immunogenicity in mice","volume":"27","author":"Samsa","year":"2019","journal-title":"Mol Ther"},{"issue":"17","key":"10.1016\/j.imj.2026.100249_bib0061","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J Virol"},{"issue":"32","key":"10.1016\/j.imj.2026.100249_bib0062","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.vaccine.2009.05.011","article-title":"Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus","volume":"27","author":"Atasheva","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0063","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.vaccine.2013.01.014","article-title":"A chimeric Sindbis-based vaccine protects Cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus","volume":"31","author":"Roy","year":"2013","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.imj.2026.100249_bib0064","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1128\/JVI.01406-14","article-title":"Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses","volume":"88","author":"Reed","year":"2014","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.imj.2026.100249_bib0065","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3390\/v14071502","article-title":"Efficacy of western, eastern, and venezuelan equine encephalitis (WEVEE) virus-replicon particle (VRP) vaccine against WEEV in a non-human primate animal model","volume":"14","author":"Burke","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.imj.2026.100249_bib0066","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.ymthe.2025.08.051","article-title":"An alphavirus vaccine development utilizing RNA replication-defective strategy","volume":"33","author":"Zhang","year":"2025","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0067","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/v8110319","article-title":"Pathogens inactivated by low-energy-electron irradiation maintain antigenic properties and induce protective immune responses","volume":"8","author":"Fertey","year":"2016","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0068","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4269\/ajtmh.2008.78.83","article-title":"Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies","volume":"78","author":"Rosas","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.imj.2026.100249_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1187193","article-title":"An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses","volume":"13","author":"Falqui","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"34","key":"10.1016\/j.imj.2026.100249_bib0070","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2018.06.064","article-title":"Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses","volume":"36","author":"Hu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.imj.2026.100249_bib0071","article-title":"A monovalent and trivalent MVA-based vaccine completely protects mice against lethal venezuelan, western, and eastern equine encephalitis virus aerosol challenge","volume":"11","author":"Henning","year":"2020","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0072","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.vaccine.2024.03.011","article-title":"Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: a phase 1 clinical trial","volume":"42","author":"Fierro","year":"2024","journal-title":"Vaccine"},{"issue":"10240","key":"10.1016\/j.imj.2026.100249_bib0073","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.imj.2026.100249_bib0074","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.vaccine.2004.06.056","article-title":"Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus","volume":"23","author":"Phillpotts","year":"2005","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.imj.2026.100249_bib0075","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/j.vaccine.2007.05.054","article-title":"Single-dose, fast-acting vaccine candidate against western equine encephalitis virus completely protects mice from intranasal challenge with different strains of the virus","volume":"25","author":"Barab\u00e9","year":"2007","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.imj.2026.100249_bib0076","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2007.03.042","article-title":"Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine","volume":"25","author":"Wu","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.imj.2026.100249_bib0077","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/infdis\/jiz137","article-title":"A highly immunogenic, protective, and safe adenovirus-based vaccine expressing middle east respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human dipeptidyl peptidase 4 mouse model","volume":"220","author":"Hashem","year":"2019","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.imj.2026.100249_bib0078","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088183","article-title":"Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus gn and S0.7 in an adenoviral vector","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.imj.2026.100249_bib0079","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01274-17","article-title":"Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge","volume":"92","author":"Erasmus","year":"2018","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.imj.2026.100249_bib0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2004.06.008","article-title":"Evaluation of a Western Equine Encephalitis recombinant E1 protein for protective immunity and diagnostics","volume":"64","author":"Das","year":"2004","journal-title":"Antiviral Res"},{"issue":"1\/2","key":"10.1016\/j.imj.2026.100249_bib0081","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virusres.2007.03.030","article-title":"Immunological evaluation of Escherichia coli expressed E2 protein of western equine encephalitis virus","volume":"128","author":"Das","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.imj.2026.100249_bib0082","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.virol.2016.08.023","article-title":"Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses","volume":"499","author":"Rico","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.imj.2026.100249_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110152","article-title":"Displaying alphavirus physicochemical consensus antigens on immunogenic liposomes enhances antibody elicitation in mice","volume":"597","author":"Huang","year":"2024","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.imj.2026.100249_bib0084","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S1473-3099(22)00052-4","article-title":"Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial","volume":"22","author":"Coates","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.imj.2026.100249_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202100008","article-title":"Western equine encephalitis virus virus-like particles from an insect cell-baculovirus system elicit the strong immune responses in mice","volume":"16","author":"Ma","year":"2021","journal-title":"Biotechnol J"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0086","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/acsomega.3c07322","article-title":"Designing a multiepitope vaccine against eastern equine encephalitis virus: immunoinformatics and computational approaches","volume":"9","author":"Nguyen","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.imj.2026.100249_bib0087","article-title":"Hierarchical design of pseudosymmetric protein nanoparticles","author":"Dowling","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.imj.2026.100249_bib0088","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3389\/fimmu.2018.01432","article-title":"New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue","volume":"9","author":"Brune","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2026.100249_bib0089","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41541-019-0125-5","article-title":"Epitope targeting with self-assembled peptide vaccines","volume":"4","author":"Zeigler","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41541-024-00954-5","article-title":"An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection","volume":"9","author":"Zhou","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"820","key":"10.1016\/j.imj.2026.100249_bib0091","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu2085","article-title":"Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice","volume":"17","author":"Hendricks","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.imj.2026.100249_bib0092","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01469-7","article-title":"Thermoreversibly assembled polymersomes for highly efficient loading, processing and delivery of protein and siRNA biologics","author":"Hossainy","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0093","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/microorganisms9050899","article-title":"Insights into antibody-mediated alphavirus immunity and vaccine development landscape","volume":"9","author":"Torres-Ruesta","year":"2021","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.imj.2026.100249_bib0094","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/pathogens10080973","article-title":"The structural biology of eastern equine encephalitis virus, an emerging viral threat","volume":"10","author":"Hasan","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.imj.2026.100249_bib0095","doi-asserted-by":"crossref","unstructured":"Perenkov A.D., Sergeeva A.D., Vedunova M.V., et al. In vitro transcribed RNA-based platform vaccines: past, present, and future. Vaccines. 2023; 11(10): 1600. https:\/\/doi.org\/10.3390\/vaccines11101600.","DOI":"10.3390\/vaccines11101600"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0096","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/v16050803","article-title":"Hepatitis C virus E1E2 structure, diversity, and implications for vaccine development","volume":"16","author":"Pierce","year":"2024","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.imj.2026.100249_bib0097","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3390\/vaccines10111920","article-title":"Vaccination strategies based on bacterial self-assembling proteins as antigen delivery nanoscaffolds","volume":"10","author":"Lamontagne","year":"2022","journal-title":"Vaccines"},{"issue":"7","key":"10.1016\/j.imj.2026.100249_bib0098","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/597275","article-title":"Identification of thieno [3, 2-b] pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses","volume":"199","author":"Peng","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.imj.2026.100249_bib0099","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41467-023-44624-x","article-title":"The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses","volume":"15","author":"Ma","year":"2024","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.imj.2026.100249_bib0100","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1128\/JVI.00410-16","article-title":"Rearrangement of influenza virus spliced segments for the development of live-attenuated vaccines","volume":"90","author":"Nogales","year":"2016","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.imj.2026.100249_bib0101","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"28","key":"10.1016\/j.imj.2026.100249_bib0102","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301495","article-title":"Broad and durable humoral responses following single hydrogel immunization of SARS-CoV-2 subunit vaccine","volume":"12","author":"Ou","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"7837","key":"10.1016\/j.imj.2026.100249_bib0103","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41586-020-2915-3","article-title":"LDLRAD3 is a receptor for Venezuelan equine encephalitis virus","volume":"588","author":"Ma","year":"2020","journal-title":"Nature"},{"issue":"7882","key":"10.1016\/j.imj.2026.100249_bib0104","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41586-021-03909-1","article-title":"Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3","volume":"598","author":"Ma","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.imj.2026.100249_bib0105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/v13050805","article-title":"To include or occlude: rational engineering of HCV vaccines for humoral immunity","volume":"13","author":"Schlotthauer","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.imj.2026.100249_bib0106","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/mps7030042","article-title":"Syrian hamsters model does not reflect human-like disease after aerosol exposure to encephalitic alphaviruses","volume":"7","author":"Gardner","year":"2024","journal-title":"Methods Protoc"},{"key":"10.1016\/j.imj.2026.100249_bib0107","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fmicb.2013.00305","article-title":"Can non-human primates serve as models for investigating dengue disease pathogenesis?","volume":"4","author":"Clark","year":"2013","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imj.2026.100249_bib0108","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2020.00592","article-title":"Current efforts in the development of vaccines for the prevention of zika and chikungunya virus infections","volume":"11","author":"Schrauf","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.imj.2026.100249_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1514940","article-title":"Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure","volume":"18","author":"VanderGiessen","year":"2024","journal-title":"Front Neurosci"}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X26000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X26000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:20:55Z","timestamp":1781022055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X26000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2772431X26000158"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2026.100249","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status on encephalitic alphavirus vaccines development: Advances, challenges, and global health perspectives","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2026.100249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100249"}}